Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATXS
3601
DELISTED
Astria Therapeutics
ATXS
| $388K | ﹤0.01% |
72,633
-25,187
| -26% | -$176K |
|
|
EBTC
3602
DELISTED
Enterprise Bancorp
EBTC
| $387K | ﹤0.01% |
9,932
-4,948
| -33% | -$203K |
|
3603
Viant Technology
DSP
$274M
| $384K | ﹤0.01% |
30,971
-6,964
| -18% | -$128K |
|
3604
Kodak
KODK
$978M
| $384K | ﹤0.01% |
60,778
-30,192
| -33% | -$210K |
|
3605
Bausch Health
BHC
$2.37B
| $384K | ﹤0.01% |
59,317
-34,206
| -37% | -$246K |
|
3606
Direxion Daily Technology Bull 3x ETF
TECL
$6.47B
| $384K | ﹤0.01% |
6,550
| – | – |
|
3607
Caledonia Mining Corp
CMCL
$439M
| $383K | ﹤0.01% |
30,667
-8,142
| -21% | -$83.6K |
|
3608
Neuropace
NPCE
$498M
| $383K | ﹤0.01% |
31,164
+3,555
| +13% | +$44.5K |
|
|
BKV
3609
BKV Corp
BKV
$2.84B
| $382K | ﹤0.01% |
18,207
-3,941
| -18% | -$89.1K |
|
|
TSVT
3610
DELISTED
2seventy bio
TSVT
| $382K | ﹤0.01% |
77,347
-13,448
| -15% | -$42.7K |
|
3611
LCNB Corp
LCNB
$285M
| $382K | ﹤0.01% |
25,817
-4,508
| -15% | -$67.7K |
|
3612
Target Hospitality
TH
$1.62B
| $382K | ﹤0.01% |
58,005
-22,549
| -28% | -$181K |
|
|
LAC
3613
Lithium Americas
LAC
$1.24B
| $381K | ﹤0.01% |
140,487
-7,146
| -5% | -$21.5K |
|
3614
Red Cat Holdings
RCAT
$1.56B
| $380K | ﹤0.01% |
64,649
-39,983
| -38% | -$320K |
|
3615
IBEX
IBEX
$482M
| $380K | ﹤0.01% |
15,592
-6,454
| -29% | -$155K |
|
3616
ReposiTrak
TRAK
$158M
| $378K | ﹤0.01% |
18,640
-2,968
| -14% | -$61.3K |
|
|
FSUN
3617
FirstSun Capital Bancorp
FSUN
$2.02B
| $377K | ﹤0.01% |
10,417
+2,017
| +24% | +$80.4K |
|
3618
Consolidated Water Co
CWCO
$502M
| $376K | ﹤0.01% |
15,371
-7,969
| -34% | -$212K |
|
3619
Forrester Research
FORR
$224M
| $376K | ﹤0.01% |
40,727
-7,036
| -15% | -$89.5K |
|
3620
Voyager Therapeutics
VYGR
$198M
| $375K | ﹤0.01% |
111,048
-3,742
| -3% | -$17.5K |
|
3621
Five Point Holdings
FPH
$372M
| $374K | ﹤0.01% |
70,087
| – | – |
|
3622
Turkcell
TKC
$4.72B
| $374K | ﹤0.01% |
60,108
+50,108
| +501% | +$353K |
|
3623
Finance of America Companies
FOA
$206M
| $372K | ﹤0.01% |
17,520
+20
| +0.1% | +$489 |
|
3624
RCI Hospitality Holdings
RICK
$230M
| $372K | ﹤0.01% |
8,673
-4,271
| -33% | -$218K |
|
3625
Distribution Solutions Group
DSGR
$1.61B
| $372K | ﹤0.01% |
13,272
-5,241
| -28% | -$163K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.